Certified by Founder
Lodge
Sift Biosciences
start up
United States
- San Carlos, CA
- 19/02/2026
- Pre-Seed
- $3,700,000
Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.
- Industry Biotechnology Research
- Website https://siftbio.com/
- LinkedIn https://www.linkedin.com/company/sift-biosciences/
Related People
Yue Clare Lou, Ph.D.Co Founder
United States -
San Francisco Bay Area
Scientist | Founder
Immunology | Cancer <> AI/Bioinformatics <> Microbiology
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
Mantis Space | $10,000,000 | (Mar 13, 2026)
Monteris Medical | $28,000,000 | (Mar 13, 2026)
Gumloop | $50,000,000 | (Mar 13, 2026)
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Qurrent | $15,000,000 | (Mar 13, 2026)
Waiv, formerly Owkin Dx | $33,000,000 | (Mar 13, 2026)
Carefam | $14,500,000 | (Mar 13, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)